| Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ... Nature medicine 20 (11), 1301-1309, 2014 | 1023 | 2014 |
| Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells LB John, C Devaud, CPM Duong, CS Yong, PA Beavis, NM Haynes, ... Clinical cancer research 19 (20), 5636-5646, 2013 | 774 | 2013 |
| Chemokines in cancer MT Chow, AD Luster Cancer immunology research 2 (12), 1125-1131, 2014 | 526 | 2014 |
| The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions CJ Chan, L Martinet, S Gilfillan, F Souza-Fonseca-Guimaraes, MT Chow, ... Nature immunology 15 (5), 431-438, 2014 | 507 | 2014 |
| Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy MT Chow, AJ Ozga, RL Servis, DT Frederick, JA Lo, DE Fisher, ... Immunity, 2019 | 469 | 2019 |
| Primary Tumor Hypoxia Recruits CD11b+/Ly6Cmed/Ly6G+ Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche J Sceneay, MT Chow, A Chen, HM Halse, CSF Wong, DM Andrews, ... Cancer research 72 (16), 3906-3911, 2012 | 391 | 2012 |
| Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors PA Beavis, U Divisekera, C Paget, MT Chow, LB John, C Devaud, ... Proceedings of the National Academy of Sciences 110 (36), 14711-14716, 2013 | 363 | 2013 |
| Chemokines and the immune response to cancer AJ Ozga, MT Chow, AD Luster Immunity 54 (5), 859-874, 2021 | 309 | 2021 |
| Inflammation and immune surveillance in cancer MT Chow, A Möller, MJ Smyth Seminars in cancer biology 22 (1), 23-32, 2012 | 281 | 2012 |
| NLRP3 suppresses NK cell–mediated responses to carcinogen-induced tumors and metastases MT Chow, J Sceneay, C Paget, CSF Wong, H Duret, J Tschopp, A Möller, ... Cancer research 72 (22), 5721-5732, 2012 | 186 | 2012 |
| A role for granzyme M in TLR4-driven inflammation and endotoxicosis DA Anthony, DM Andrews, M Chow, SV Watt, C House, S Akira, PI Bird, ... The Journal of Immunology 185 (3), 1794-1803, 2010 | 111 | 2010 |
| Chemokines in cancer. Cancer Immunol. Res. 2014; 2: 1125–1131. doi: 10.1158/2326-6066 MT Chow, AD Luster CIR-14-0160.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 2014 | 84 | 2014 |
| NLRP3 promotes inflammation‐induced skin cancer but is dispensable for asbestos‐induced mesothelioma MT Chow, J Tschopp, A Möller, MJ Smyth Immunology and cell biology 90 (10), 983-986, 2012 | 84 | 2012 |
| CD3bright signals on γδ T cells identify IL‐17A‐producing Vγ6Vδ1+ T cells C Paget, MT Chow, NA Gherardin, PA Beavis, AP Uldrich, H Duret, ... Immunology and cell biology 93 (2), 198-212, 2014 | 74 | 2014 |
| Role of γδ T Cells in α-Galactosylceramide–Mediated Immunity C Paget, MT Chow, H Duret, SR Mattarollo, MJ Smyth The Journal of Immunology 188 (8), 3928-3939, 2012 | 64 | 2012 |
| Toll-like receptor 3 regulates NK cell responses to cytokines and controls experimental metastasis C Guillerey, MT Chow, K Miles, S Olver, J Sceneay, K Takeda, A Möller, ... Oncoimmunology 4 (9), e1027468, 2015 | 48 | 2015 |
| CXCL10 chemokine regulates heterogeneity of the CD8+ T cell response and viral set point during chronic infection AJ Ozga, MT Chow, ME Lopes, RL Servis, M Di Pilato, P Dehio, J Lian, ... Immunity 55 (1), 82-97. e8, 2022 | 36 | 2022 |
| Type I NKT‐cell‐mediated TNF‐α is a positive regulator of NLRP 3 inflammasome priming MT Chow, H Duret, DM Andrews, C Faveeuw, A Möller, MJ Smyth, ... European Journal of Immunology 44 (7), 2111-2120, 2014 | 20 | 2014 |
| Homeostatic defects in interleukin 18‐deficient mice contribute to protection against the lethal effects of endotoxin DM Andrews, MT Chow, Y Ma, CL Cotterell, SV Watt, DA Anthony, S Akira, ... Immunology and cell biology 89 (6), 739-746, 2011 | 20 | 2011 |
| Degradation of PIP4K2C by novel bivalent functional degrader LRK-A induces tumor regression in CRC E Corse, K Goodman, M O'Shea, G Ye, M Chow, J Arnold, V Giacalone, ... Cancer Research 84 (6_Supplement), 5574-5574, 2024 | | 2024 |
